Research Nester Logo.jpg
Chronic Disease Management Market revenue to reach USD 27 Billion by 2035, says Research Nester
13 mars 2024 07h30 HE | Research Nester
New York, March 13, 2024 (GLOBE NEWSWIRE) -- The global chronic disease management market size is projected to grow at a CAGR of over ~13% from 2023 to 2035. The market is expected to garner a...
DBCV5352_CCC2022-iPhone-preview
Annual Cycling Event in California Raises Over $1 Million to Fight Arthritis, Impacting Nearly 60 Million Adults and Hundreds of Thousands of Children in the U.S. The 23rd California Coast Classic Bike Tour presented by Amgen, kicks off Saturday in San Francisco en route to Los Angeles with two hundred cyclists.
AOFAS and the Arthri
AOFAS and the Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
19 sept. 2023 15h00 HE | American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) and the Arthritis Foundation (AF) announced the recipients of the first-ever AF/AOFAS...
Sept Canadiens sur d
Sept Canadiens sur dix craignent d’être atteints d’arthrite un jour, ou de l’être déjà
07 sept. 2023 09h04 HE | Arthritis Society Canada
TORONTO, 07 sept. 2023 (GLOBE NEWSWIRE) -- Une nouvelle enquête nationale révèle que sept Canadiens sur dix craignent d’être atteints d’arthrite un jour ou de l’être déjà. Septembre est le Mois de...
images.png
Seven-in-10 Canadians fear getting arthritis, or fear they already have it
07 sept. 2023 09h04 HE | Arthritis Society Canada
TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- A new, national survey finds that seven-in-10 Canadians are worried about getting arthritis, or worried that they already have it. September is Arthritis...
ihl_logo.png
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
13 juil. 2023 08h00 HE | Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
logo.png
Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
11 avr. 2023 05h00 HE | Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
factMR-logo.png
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis
06 mars 2023 14h00 HE | FACT.MR
Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027. Patients in Europe and North America would push demand for...
facts-and-factors.jpg
[Latest] Global Psoriatic Arthritis Market Size/Share Worth USD 22.23 Billion by 2030 at a 11.35% CAGR: Facts & Factors (Industrial Trends, Report, Analysis, Players, Outlook, Forecast, Growth, Value, Segmentation)
09 févr. 2023 05h54 HE | Facts & Factors
NEW YORK, USA, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Psoriatic Arthritis Market Size, Share, Growth Analysis Report By Route Of...
AOFAS and the Arthri
AOFAS and the Arthritis Foundation Launch Grants Program to Fuel Ankle Arthritis Research
27 janv. 2023 10h13 HE | American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Jan. 27, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society® (AOFAS) and the Arthritis Foundation (AF) announced the opening of the first-ever AF/AOFAS Ankle...